Obesity and type 2 diabetes (T2D) are characterized not only by metabolic disorder, but also by chronic low-grade inflammation, contributing to systemic and neural dysfunction (1, 2). Toll-like receptor 4 (TLR4), a pattern recognition receptor of the innate immune system, plays a central role in this process (3). TLR4 is activated by dietary lipids, such as saturated fatty acids, and bacterial lipopolysaccharides (LPS), triggering downstream MyD88- and TRIF-dependent signaling cascades that lead to the production of pro-inflammatory cytokines (4–6). Through these mechanisms, TLR4 acts as a molecular link between overnutrition, inflammation, and insulin resistance.
High fat diets (HFD) are widely used in rodent models to induce insulin resistance, hepatic steatosis and obesity (7). Studies in TLR4 knockout (TLR4 KO) mice have shown partial protection against diet-induced metabolic dysfunction and weight gain, highlighting the importance of TLR4 in the progression of these metabolic disorders (8, 9). Beyond metabolic dysfunction, diet-induced obesity and insulin resistance have been increasingly associated with alterations in the central nervous system and brain function, resulting in neurocognitive dysfunction, including anxiety, depression and memory discrepancies (10).
While much attention has focused on the role of HFDs in TLR4-mediated obesity, inflammation, and metabolic dysfunction, far less is known about the impact of diets combining high fat with high sucrose (HS). Emerging evidence suggests that sucrose itself can drive inflammatory changes (11). Both overnutrition and sucrose-rich diets are implicated in early cognitive deficits. Rodent models have demonstrated changes in locomotor activity, energy balance and anxiety-like behaviors (12, 13). In fact, one study on the impact of HFD on TLR4 KO mice showed that TLR4 KO mice performed similarly in a Morris water maze and found the platform in both the HFD and normal diet group, where wild-type mice on the HFD took significantly longer, indicating a decline in cognitive function (14). Although extensive evidence links TLR4 and HFDs to metabolic dysfunction and behavioral changes, the contribution of HS remains unclear. This study attempts to address this gap by investigating the impacts of HS-HFDs on TLR4 -mediated cognitive dysfunction.